Tenapanor Completed Phase 4 Trials for End Stage Renal Disease (ESRD) / Hyperphosphataemia Treatment

IndicationsStatusPurposePhase
CompletedTreatment4
clinicaltrials.gov IdentifierTitleDrugs
NCT03988920A Long-Term Study of Tenapanor Alone or in Combination With Sevelamer in Patients With CKD on Dialysis and HP